Drug
Spk 8011qq
Spk 8011qq: highest development phase Phase 1/2, developed by Roche. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| SPK-8011QQ NCT07226206 | Phase 1/2 | Hemophilia A |
Latest
No recent events.
Follow Spk 8011qq on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.